LIN vs SEM · P/E 34, rev $33.99B vs P/E 15, rev $1.31B
Linde plc Ordinary Shares (LIN) versus Select Medical Holdings (SEM) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Select Medical Holdings (SEM) is a medical care facilities company listed on NYSE.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Latest reported SEM revenue for 2024-12-31 was $1.31B. Net income was $3.8M. Revenue was up 3.2% from 2024-09-30 to 2024-12-31. SEM currently screens at market cap $2.05B and trailing P/E 15.5.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. SEM currently screens at market cap $2.05B and trailing P/E 15.5.
Not investment advice. Open the LIN and SEM stock pages for the full models.
Not investment advice.